Publications by authors named "M Delomez"
Objectives: Report contemporary outcomes in patients included in the Mitragister registry and treated with transcatheter mitral valve implantation for failed surgical annuloplasty rings or deteriorated bioprosthesis.
Background: Midterm survival rates have been reported, but little is known about contemporary morbimortality endpoints.
Methods: The primary safety outcome was the technical success rate.
Article Synopsis
- Surgical aortic valve replacement (SAVR) is recommended for low-risk patients, while the Heart Team should decide between transcatheter aortic valve implantation (TAVI) and surgery for others, with a preference for TAVI in older patients.
- A multicenter study surveyed 1,049 patients aged 75 and older to understand the role of age and surgical risk in treatment decisions for severe aortic stenosis, finding that TAVI was preferred in 71% of cases.
- The study revealed that as age increases, particularly after 80, the influence of surgical risk scores on treatment decisions decreases significantly, leading most patients to be referred for TAVI even if they have low surgical risk; however, 10%
Background: Transcatheter aortic valve replacement (TAVR) is standard therapy for patients with severe aortic stenosis who are at high surgical risk. However, national data regarding procedural characteristics and clinical outcomes over time are limited.
Objectives: The aim of this study was to assess nationwide performance trends and clinical outcomes of TAVR during a 6-year period.
Background: Current data are lacking for incidence, correlates, and prognosis associated with incident myocardial infarction (MI) in patients with stable coronary artery disease (CAD). Furthermore, the contribution of very late stent thrombosis (VLST) to these events remains poorly understood.
Objectives: This study aimed to analyze the residual risk of MI, together with relevant associated factors, and related mortality in stable CAD outpatients.
Background: The prevalence and correlates of dual-antiplatelet therapy (DAPT) use in stable coronary artery disease (CAD) are unknown. In addition, whether prolonged DAPT may impact prognosis in stable CAD has not been studied in real-life conditions.
Methods: We studied 3,691 patients included in a prospective registry on stable CAD.